[1] |
ZENG Lijie, WANG Liang, YANG Lei .
Clinical features and treatment efficacy analysis of central nervous system involvement in extranodal nasal-type natural killer/T-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 81-87.
|
[2] |
GUO Zhiyu, CAO Tianyu, WANG Weidong, GUO Xingxian, MA Wanqi, LU Yuanyuan, ZHAO Xiaodi, JI Gang.
Correlation between blood lipid levels and survival prognosis of gastric cancer patients under operation: A retrospective cohort study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 687-693.
|
[3] |
DONG Junling, YANG Hui, LI Na.
Trend of the incidence of gastric cancer in China,1992—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 593-597.
|
[4] |
YAN Haiqing, LAI Qinqiao, WU Liucheng, WANG Ting'an, XIA Xiang, HUANG Mingwei, QIN Yuzhou.
Effects of SH3BGRL on proliferation and migration of gastric cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 285-294.
|
[5] |
QIN Liming, ZHOU Zihan, CAO Ji, LI Qiulin, YU Jiahua, RONG Minhua, ZHAO Libin, MAI Yuejiao, GE Lianying, QIN Yuzhou, YU Hongping.
Epidemiological characteristics and disease burden analysis of gastric cancer in Guangxi,2011—2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 172-178.
|
[6] |
MA Fuchao, LIU Aiquan, XIE Weishun, SHEN Yanhua, FENG Jie, JIANG Qi, GE Lianying.
Screening and diagnostic efficacy evaluation of risk miRNAs during the development of gastric cancer: a multicenter study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 193-199.
|
[7] |
WU Lili, ZHU Yingli, ZHUO Xiaolu, HUANG Lina, YE Dong.
Comparison of clinical efficacy of icotinib and gefitinib in the treatment of EGFR⁃mutated advanced lung adenocarcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(6): 642-646.
|
[8] |
LUO Xixi, CHEN Jiamei, SHI Wei, CHEN Yongshun.
Efficacy and safety of Regorafenib combined with PD⁃1 inhibitors in advanced microsatellite stable colorectal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 521-528.
|
[9] |
CHEN Xiaolei, ZHANG Yong, ZHANG Yue, LI Jie, ZHOU Hebing .
Retrospective analysis of efficacy and prognosis of newly diagnosed multiple myeloma patients with 1q21 amplification
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 541-547.
|
[10] |
CHEN Minggan, GONG Qinghao, DAI Gang, ZHANG Meifeng, ZHANG Jie.
Predictive value of preoperative albumin to alkaline phosphatase ratio in the prognosis of patients after radical gastrectomy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(4): 407-411.
|
[11] |
JIANG Jian, ZUO Yun, NI Chen, ZHU Huiping.
Effect of Apatinib on radiosensitivity of gastric cancer HGC⁃27 cells and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(2): 154-159.
|
[12] |
LI Daimou, WU Liucheng, LIANG Banghui, PAN Jiayu, WANG Ting'an, WEI Weiyuan, JIN Qinwen, LING Tong, HUANG Mingwei, QIN Yuzhou.
Analysis of the characteristics of diffuse gastric cancer and expression of hub gene LUM based on transcriptome sequencing
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(2): 160-166.
|
[13] |
cancerZHOU Gaoyun, LIN Long, LIN Jinwei, SU Dewen.
Predictive value of MLH1 expression on prognosis and preoperative neoadjuvant chemotherapy response in patients with gastric
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(1): 65-69.
|
[14] |
WANG Zimeng, XIANG Zuolin.
Clinical efficacy of stereotactic body radiation therapy on liver metastases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 641-646.
|
[15] |
CAI Xinlian, HUANG Yueli, ZHONG Yi, LIU Aiqun.
Analysis of the opportunistic screening results of upper gastrointestinal cancer in Guangxi,2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 662-666.
|